Erin Morris

772 total citations
30 papers, 546 citations indexed

About

Erin Morris is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Erin Morris has authored 30 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 10 papers in Oncology and 8 papers in Genetics. Recurrent topics in Erin Morris's work include Hematopoietic Stem Cell Transplantation (14 papers), Acute Lymphoblastic Leukemia research (7 papers) and Hemoglobinopathies and Related Disorders (6 papers). Erin Morris is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Acute Lymphoblastic Leukemia research (7 papers) and Hemoglobinopathies and Related Disorders (6 papers). Erin Morris collaborates with scholars based in United States, Switzerland and Poland. Erin Morris's co-authors include Mitchell S. Cairo, Prakash Satwani, Monica Bhatia, James H. Garvin, Lauren Harrison, Joseph E. Schwartz, G. Del Toro, M.B. Bradley, Lee Ann Baxter‐Lowe and Thomas G. Gross and has published in prestigious journals such as Blood, Frontiers in Immunology and Organic Letters.

In The Last Decade

Erin Morris

28 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erin Morris United States	14	287	172	123	121	88	30	546
Olga Militano United States	12	247 0.9×	176 1.0×	78 0.6×	55 0.5×	134 1.5×	42	446
Steve Andresen United States	12	289 1.0×	183 1.1×	57 0.5×	140 1.2×	64 0.7×	30	524
Nan Young Lee South Korea	14	306 1.1×	174 1.0×	37 0.3×	95 0.8×	64 0.7×	41	545
Rayaz Ahmed India	12	286 1.0×	104 0.6×	53 0.4×	105 0.9×	110 1.3×	55	459
Giuseppe Console Italy	15	475 1.7×	302 1.8×	38 0.3×	87 0.7×	60 0.7×	51	633
Sharon Avery Australia	13	272 0.9×	161 0.9×	96 0.8×	101 0.8×	95 1.1×	42	524
Chloe Anthias United Kingdom	12	385 1.3×	64 0.4×	49 0.4×	68 0.6×	157 1.8×	30	514
Tanya L. Pedersen United States	8	479 1.7×	107 0.6×	64 0.5×	77 0.6×	283 3.2×	11	610
BJ Bolwell United States	13	383 1.3×	331 1.9×	35 0.3×	74 0.6×	111 1.3×	19	685
Lynne Kaminer United States	14	219 0.8×	170 1.0×	19 0.2×	175 1.4×	58 0.7×	23	510

Countries citing papers authored by Erin Morris

Since Specialization

Citations

This map shows the geographic impact of Erin Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Morris more than expected).

Fields of papers citing papers by Erin Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Morris. The network helps show where Erin Morris may publish in the future.

Co-authorship network of co-authors of Erin Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Morris. A scholar is included among the top collaborators of Erin Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Morris. Erin Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hochberg, Jessica, Qiuhu Shi, Yaya Chu, et al.. (2024). Defibrotide Reduces Hypercoagulable State in Patients with Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812). Blood. 144(Supplement 1). 2515–2515. 1 indexed citations

Chu, Yaya, Julie‐An Talano, Lee Ann Baxter‐Lowe, et al.. (2022). Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease. Frontiers in Immunology. 13. 1055497–1055497. 1 indexed citations

Audino, Anthony, Matthew J. Barth, Janet Ayello, et al.. (2019). Polatuzumab Vedotin, an Antibody-Drug Conjugate Targeting CD79b, Is a Highly Active Agent Against Burkitt Lymphoma and Primary Mediastinal B-Cell Lymphoma. Blood. 134(Supplement_1). 3963–3963. 3 indexed citations

Talano, Julie‐An, Carolyn A. Keever-Taylor, Mark C. Walters, et al.. (2017). Familial Haploidentical (FHI) T-Cell Depleted (TCD) with T-Cell Addback Stem Cell Transplantation for Patients with High-Risk Sickle Cell Disease (SCD) (IND 14359). Biology of Blood and Marrow Transplantation. 23(3). S246–S247. 1 indexed citations

Bhatia, Monica, Zhezhen Jin, Claire E. Baker, et al.. (2014). Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease. Bone Marrow Transplantation. 49(7). 913–920. 75 indexed citations

Palmer, Mary H., et al.. (2014). Hydrate for Health: Listening to Older Adults’ Need for Information. Journal of Gerontological Nursing. 40(10). 24–30. 2 indexed citations

Vaughan, K.T. L., et al.. (2013). Development of the research lifecycle model for library services. Journal of the Medical Library Association JMLA. 101(4). 310–314. 37 indexed citations

Satwani, Prakash, Zhezhen Jin, Erin Morris, et al.. (2012). Transplantation-Related Mortality, Graft Failure, and Survival after Reduced-Toxicity Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation in 100 Consecutive Pediatric Recipients. Biology of Blood and Marrow Transplantation. 19(4). 552–561. 55 indexed citations

George, Diane, Nader Kim El‐Mallawany, Zhezhen Jin, et al.. (2011). Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality. British Journal of Haematology. 156(1). 99–108. 22 indexed citations

10.

Shiramizu, Bruce, Stanton Goldman, James C. Lynch, et al.. (2011). Minimal disease assessment in the treatment of children and adolescents with intermediate‐risk (Stage III/IV) B‐cell non‐Hodgkin lymphoma: a children’s oncology group report. British Journal of Haematology. 153(6). 758–763. 23 indexed citations

11.

Morris, Erin, et al.. (2011). Diels–Alder Cycloaddition of Chiral Nonracemic 2,5-Diketopiperazine Dienes. Organic Letters. 13(16). 4430–4433. 15 indexed citations

12.

Styczyński, Jan, Ian M. Waxman, Carmella van de Ven, et al.. (2010). A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents. Bone Marrow Transplantation. 46(6). 790–799. 29 indexed citations

13.

Bhatia, Monica, Olga Militano, Zhezhen Jin, et al.. (2009). An Age-Dependent Pharmacokinetic Study of Intravenous and Oral Mycophenolate Mofetil in Combination with Tacrolimus for GVHD Prophylaxis in Pediatric Allogeneic Stem Cell Transplantation Recipients. Biology of Blood and Marrow Transplantation. 16(3). 333–343. 52 indexed citations

14.

Militano, Olga, Monica Bhatia, Zhezhen Jin, et al.. (2009). Pharmacokinetics (PK) Of IV And Po Mycophenolate Mofetil (MMF) In Age Adjusted Pediatric And Adolescent Allogeneic Stem Cell Transplant (AlloSCT) Recipients: Significantly Higher CLss AND Vss IN PATIENTS <6 YEARS OF AGE. Biology of Blood and Marrow Transplantation. 15(2). 132–133.

15.

Waxman, Ian M., Olga Militano, Erin Morris, et al.. (2008). Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning^†. Pediatric Transplantation. 13(4). 464–474. 18 indexed citations

16.

Bradley, M.B., Prakash Satwani, Erin Morris, et al.. (2007). Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. Bone Marrow Transplantation. 40(7). 621–631. 60 indexed citations

17.

Satwani, Prakash, G. Del Toro, M.B. Bradley, et al.. (2006). 3: Reduced Intensity (RI) aLlogeneic Cord Blood Hematopoietic Cell Transplantation (Allo-CBHCT) in Pediatric Patients with Malignant and Non-Malignant Diseases. Biology of Blood and Marrow Transplantation. 12(11). 1218–1218. 3 indexed citations

18.

Satwani, Prakash, Lauren Harrison, Erin Morris, G. Del Toro, & Mitchell S. Cairo. (2005). Reduced-Intensity Allogeneic Stem Cell Transplantation in Adults and Children with Malignant and Nonmalignant Diseases: End of the Beginning and Future Challenges. Biology of Blood and Marrow Transplantation. 11(6). 403–422. 34 indexed citations

19.

Sabesan, Vani J., Mitchell S. Cairo, Mark A. Lones, et al.. (2003). Assessment of Minimal Residual Disease in Childhood Non-Hodgkin Lymphoma by Polymerase Chain Reaction Using Patient-Specific Primers. Journal of Pediatric Hematology/Oncology. 25(2). 109–113. 14 indexed citations

20.

Orjuela, Manuela, Thomas G. Gross, Ying‐Kuen Cheung, et al.. (2003). A pilot study of chemoimmunotherapy (cyclophosphamide, prednisone, and rituximab) in patients with post-transplant lymphoproliferative disorder following solid organ transplantation.. PubMed. 9(10 Pt 2). 3945S–52S. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact